Choose the year that you want to look at.

Please scroll horizontally.

Title Authors Journal Year Vol Pages
NDUFA12 as a functional target of the anticancer compound Ertredin in human hepatoma cells as revealed by label-free chemical proteomics. S. I. Park, S. M. Cho, S. Atsumi, M. Kawada, M. Shibuya, J. Y. Lee, J. Y. Kim, and H. J. Kwon J. Proteome Res. 2024 23 130-141, doi: org/10.1021/acs.jproteome.3c00471
Reclassification of a reveromycin-producer and the proposals of Actinacidiphila reveromycinica sp. nov. and Actinacidiphila acidipaludis comb. nov. H. Komaki, H. Takagi, S. Takahashi, and H. Osada Biosci Biotechnol Biochem 2024 DOI: 10.1093/bbb/zbae032
Identification of a family of species-selective complex I inhibitors as potential anthelmintics. T. Davie, X. Serrat, L. Imhof, J. Snider, I. Štagljar, J. Keiser, H. Hirano, N. Watanabe, H. Osada, and A. G. Fraser Nat Commun. 2024 15 3367.
Macrophage/microglia-producing transient increase of platelet-activating factor is involved in neuropathic pain. S. Yamamoto, T. Hashidate-Yoshida, Y. Yoshinari, T. Shimizu, and H. Shindou iScience 2024 27
Inhibition of kynurenine production by N, O-substituted hydroxylamine derivatives. M. Iijima, Y. Otsuka, S. Ohba, and I. Momose Bioorg. Med. Chem. Lett. 2024 106 129731
Synthesis of heteroaromatic-fused cyclic β-amino acids by rhodium-catalyzed electrophilic amination. R. Manoharan, Y. Asada, H. Noda, and M. Shibasaki Synthesis 2024 DOI: 10.1055/a-2282-7450
Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies. T. Arimori , E. Mihara, H. Suzuki, T. Ohishi, T. Tanaka, M. K. Kaneko, J.Takagi, and Y. Kato Structure 2024
Direct catalytic enantioselective conjugate addition of α‑substituted benzyl nitriles to alkyl acrylates. S. Samanta, J. Cui, Y. Otsuka, T. Watanabe, and M. Shibasaki Org. Lett. 2024
Impact of perinatal maternal docosahexaenoic acid-containing phospholipid synthesis on offspring growth and neurological symptoms. A. Kanatani, D. Hishikawa, K. Nagata, F. Hamano. K. Nakano, T. Okamura, T. Shimizu, H. Shindou, T. Nagamatsu, and K. Yanagida bioRxiv 2024
Lysophospholipid acyltransferase 9 promotes emphysema formation via platelet-activating factor. H. Murano, S. Inoue, T. H. Yoshida, H. Shindou, T. Shimizu, Y. Otaki, Y. Minegishi, T. Kitaoka, M. Futakuchi, A. Igarashi, M. Nishiwaki, T. Nemoto, M. Sato, M. Kobayashi, K. Sato, T. Hanawa, O. Miyazaki, and M. Watanabe Am. J. Respir. Cell Mol. Biol. 2024
Precursor-directed biosynthesis and biological activity of tripropeptin Cpip, a new tripropeptin C analog containing pipecolic acid. H. Hashizume, R. Sawa, Y. Kubota, S. Adachi, S. Harada, and M. Igarashi J. Antibiot. 2024
Analysis of the valgamicin biosynthetic pathway reveals a general mechanism for cyclopropanol formation across diverse natural product scaffolds. R. F. Little, F. Trottmann, H. Hashizume, M. Preissler, S. Unger, R. Sawa, H. Kries, S. Pidot, M. Igarashi, and C. Hertweck ACS Chem. Biol. 2024
A cancer-specific monoclonal antibody against HER2 exerts antitumor activities in human breast cancer xenograft models. M. K. Kaneko., H. Suzuki, T. Ohishi, T. Nakamura, T. Tanaka, and Y. Kato Int. J. Mol. Sci. 2024 25 1941. doi: 10.3390/ijms25031941.
Catenulopyrizomicins, new anti-Hepatitis B virus compounds, from the rare actinomycete Catenuloplanes sp. MM782L-181F7. M. Yamasaki, R. Sawa, H. Muramatsu, Y. Yamamoto, M. Umekita, Y. Kubota, Y. Kanegae, and M. Igarashi J. Antibiot. 2024 77 85-92. doi: 10.1038/s41429-023-00681-4.
A cancer-specific monoclonal antibody against podocalyxin exerted antitumor activities in pancreatic cancer xenografts. H. Suzuki, T. Ohishi, T. Tanaka, M. K. Kaneko, and Y. Kato Int J. Mol. Sci. 2024 25 161.